Clients often ask us to advise them as to what percentage of their caseload should comprise non-analytic cases. There are many factors to consider when responding to this question because each state registry has specific reporting requirements for non-analytic cases.
For example, if your facility’s state requires the reporting of patients who are seen only for consults or for staging workup after being diagnosed elsewhere, this can greatly contribute to your facility’s non-analytic caseload. Large academic centers often fall into this category since they receive many referrals for patients that are seen for consultation only. Academic centers may also see a significant number of non-analytic patients who present with a recurrence of cancer or disease progression since these centers offer clinical trials that may not be available elsewhere. It is not unlikely for these types of facilities to have a significantly larger percentage of non-analytic cases in comparison to analytic cases. In addition, your state may require the reporting of patients seen at your facility with a history of cancer. This can also contribute significantly to the number of non-analytic cases.
Ask yourself the following questions when analyzing your percentage of non-analytic cases:
Does your facility collect pathology-only cases?
What about patients who are diagnosed and receive all of their first course treatment in a staff physician’s office? These factors can also significantly impact your non-analytic caseload.
Does your facility provide chemotherapy and radiation therapy services? These services also draw in patients with recurrences or progression of disease. You often have to look beyond pathology reports when casefinding to identify non-analytic cases.
How thorough is your casefinding process?
For our CHAMPS Oncology clients, we find that the overall percentage of non-analytic cases seen across all states is just under 8% but varies greatly from state to state. For states that only require reporting of patients seen for recurrence or progression of disease, the percentage is considerably lower in the 4-6% range while in other states, the percentages may be in the 12-21% range.
What is your facility’s experience with non-analytic cases? Leave a comment below.
CHAMPS Oncology will attend, exhibit and present at the National Cancer Registrar Association's (NCRA) 46th Annual Educational Conference that is taking place virtually Monday, Sept. 21 through Wednesday, Sept. 23.
CHAMPS Oncology Regional Manager Amanda Harvey-McKee, BA, CTR, will be presenting during the Registry Management Symposium portion of the conference. Her presentation, Transform Your Cancer Program with the Data You Collect, will take place during the conference. Check back for more details on her presentation as the conference date approaches!
Visit our booth to learn about our cancer registry careers and see if you have what it takes to join our team!
Learn more about the NCRA 46th Annual Educational Conference by visiting their website.
Where: ONLINE - VIRTUAL FORMAT
When: Sep 21, 2020 12:00 AM - 12:00 AM
ACCC 46th Annual Meeting & Cancer Center Business Summit
CHAMPS Oncology will attend and exhibit at the Association of Community Cancer Centers (ACCC) 45th Annual Meeting and Cancer Center Business Summit.
Follow the hashtag #AMCCBS to stay connected or visit their website here.
Where: Washington Hilton, DC
When: Mar 4, 2020 -
CHAMPS Oncology Annual Meeting: 2020 Cancer Program Insights
CHAMPS Oncology's Annual Meeting: 2020 Cancer Program Insights will be held Wednesday, Jan. 29 from 8 a.m. - 12 p.m. Register now to attend our free, in-person meeting.
What are the objectives?
Review NEW CoC Standards.
Receive NEW Compliance at a Glance Tool.
Ensure you're prepared for your first quarter cancer committee.
Who should attend?
Certified Tumor Registrars (CTRs)
Cancer Service Line Leaders
Cancer Committee Members
Follow #CHAMPSAnnualMeeting to stay connected.
Can't attend in person? Downloadable version and CEs will be available for purchase.
Interested in joining the CHAMPS Oncology team and learning about our rich history? Watch this video detailing our team's 40+ years of cancer registry experience and then apply here:https://bit.ly/3jiXfXF
Stay current with your cancer registry — let CHAMPS Oncology implement our concurrent abstracting for you. Our methods provide your organization with timely cancer registry data, so you can focus on saving lives. Find out more about our tested and proven approach that is making waves in the industry:https://bit.ly/3aJAjh7